Retension Pharmaceuticals Applies for Listing on NASDAQ
2026-09-19 05:19:41
According to CoinMeta, as reported by Reuters, Retension Pharmaceuticals has applied to list on NASDAQ, with the stock code being Rtsn.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.